Literature DB >> 32717434

Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation.

Hemant S Murthy1, Raad Z Gharaibeh2, Zeina Al-Mansour1, Andrew Kozlov3, Gaurav Trikha4, Rachel C Newsome5, Josee Gauthier5, Nosha Farhadfar1, Yu Wang6, Debra Lynch Kelly7, John Lybarger4, Christian Jobin2, Gary P Wang3, John R Wingard8.   

Abstract

Infection is a major cause of morbidity and mortality after hematopoietic cell transplantation (HCT). Gut microbiota (GM) composition and metabolites provide colonization resistance against dominance of potential pathogens, and GM dysbiosis following HCT can be deleterious to immune reconstitution. Little is known about the composition, diversity, and evolution of GM communities in HCT patients and their association with subsequent febrile neutropenia (FN) and infection. Identification of markers before HCT that predict subsequent infection could be useful in developing individualized antimicrobial strategies. Fecal samples were collected prospectively from 33 HCT recipients at serial time points: baseline, post-conditioning regimen, neutropenia onset, FN onset (if present), and hematologic recovery. GM was assessed by 16S rRNA sequencing. FN and major infections (ie, bloodstream infection, typhlitis, invasive fungal infection, pneumonia, and Clostridium difficile enterocolitis) were identified. Significant shifts in GM composition and diversity were observed during HCT, with the largest alterations occurring after initiation of antibiotics. Loss of diversity persisted without a return to baseline at hematologic recovery. GM in patients with FN was enriched in Mogibacterium, Bacteroides fragilis, and Parabacteroides distasonis, whereas increased abundance of Prevotella, Ruminococcus, Dorea, Blautia, and Collinsella was observed in patients without fever. A baseline protective GM profile (BPGMP) was predictive of protection from major infection. The BPGMP was associated with subsequent major infections with 77% accuracy and an area under the curve of 79%, with sensitivity, specificity, and positive and negative predictive values of 0.71, 0.91, 0.77, and 0.87, respectively. Our data show that large shifts in GM composition occur early after HCT, and differences in baseline GM composition are associated with the development of subsequent major infections.
Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic cell transplantation; Infection; Microbiota

Mesh:

Substances:

Year:  2020        PMID: 32717434     DOI: 10.1016/j.bbmt.2020.07.023

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  3 in total

1.  Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation.

Authors:  Jose F Camargo; Anthony D Anderson; Yoichiro Natori; Akina Natori; Michele I Morris; Denise Pereira; Krishna V Komanduri
Journal:  Blood Adv       Date:  2020-12-22

2.  Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Riccardo Masetti; Federica D'Amico; Daniele Zama; Davide Leardini; Edoardo Muratore; Marek Ussowicz; Jowita Fraczkiewicz; Simone Cesaro; Giulia Caddeo; Vincenza Pezzella; Tamara Belotti; Francesca Gottardi; Piero Tartari; Patrizia Brigidi; Silvia Turroni; Arcangelo Prete
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

Review 3.  The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma.

Authors:  Sarah A Holstein; Nizar Bahlis; P Leif Bergsagel; Manisha Bhutani; Niccolo Bolli; Carrie Brownstein; Pierre Demolis; David Foureau; Francesca Gay; Irene M Ghobrial; Nicole Gormley; Jens Hillengass; Martin Kaiser; Marcela V Maus; J Joseph Melenhorst; Maximilian Merz; Michael O Dwyer; Bruno Paiva; Marcelo C Pasquini; Nina Shah; Sandy W Wong; Saad Z Usmani; Philip L McCarthy
Journal:  Transplant Cell Ther       Date:  2021-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.